IN2015KN00370A - - Google Patents

Download PDF

Info

Publication number
IN2015KN00370A
IN2015KN00370A IN370KON2015A IN2015KN00370A IN 2015KN00370 A IN2015KN00370 A IN 2015KN00370A IN 370KON2015 A IN370KON2015 A IN 370KON2015A IN 2015KN00370 A IN2015KN00370 A IN 2015KN00370A
Authority
IN
India
Prior art keywords
skin
photoaging
signs
essential oil
aging
Prior art date
Application number
Other languages
English (en)
Inventor
Agnès Pegeon
Pascale Pelletier
Pierre Lartaud
Corinne Ferraris
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR1257885A external-priority patent/FR2994528B1/fr
Priority claimed from FR1257886A external-priority patent/FR2994529B1/fr
Application filed by Oreal filed Critical Oreal
Publication of IN2015KN00370A publication Critical patent/IN2015KN00370A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
IN370KON2015 2012-08-20 2013-08-20 IN2015KN00370A (enrdf_load_stackoverflow)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR1257885A FR2994528B1 (fr) 2012-08-20 2012-08-20 Utilisation cosmetique de l'huile essentielle de laserpitium siler l. contre les signes cutanes du vieillissement.
FR1257886A FR2994529B1 (fr) 2012-08-20 2012-08-20 Utilisation cosmetique de l'huile essentielle de laserpitium siler l., a titre d'agent antioxydant.
US201261714953P 2012-10-17 2012-10-17
US201261714991P 2012-10-17 2012-10-17
PCT/IB2013/056750 WO2014030117A2 (en) 2012-08-20 2013-08-20 Cosmetic use of the essential oil of laserpitium siler l. against the signs of aging of the skin and as an antioxidant

Publications (1)

Publication Number Publication Date
IN2015KN00370A true IN2015KN00370A (enrdf_load_stackoverflow) 2015-07-10

Family

ID=50150441

Family Applications (1)

Application Number Title Priority Date Filing Date
IN370KON2015 IN2015KN00370A (enrdf_load_stackoverflow) 2012-08-20 2013-08-20

Country Status (7)

Country Link
US (2) US10328018B2 (enrdf_load_stackoverflow)
EP (1) EP2885055B1 (enrdf_load_stackoverflow)
JP (1) JP6382197B2 (enrdf_load_stackoverflow)
CN (1) CN105050662B (enrdf_load_stackoverflow)
ES (1) ES2714948T3 (enrdf_load_stackoverflow)
IN (1) IN2015KN00370A (enrdf_load_stackoverflow)
WO (1) WO2014030117A2 (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3015281B1 (fr) * 2013-12-20 2016-01-22 Oreal Utilisation cosmetique d'une huile essentielle de laserpitium siler l. pour eclaircir les matieres keratiniques
FR3015282B1 (fr) 2013-12-20 2016-01-22 Oreal Utilisation cosmetique d'une huile essentielle de laserpitium siler l. pour les matieres keratiniques.
JP6572337B2 (ja) * 2018-02-28 2019-09-04 株式会社ファンケル マイオカイン産生促進用組成物
KR102485259B1 (ko) * 2018-03-27 2023-01-06 (주)아모레퍼시픽 모발 상태 개선용 액상 지질 복합 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2796990B2 (ja) 1989-05-10 1998-09-10 株式会社資生堂 肌用化粧料
WO1999047110A1 (en) 1998-03-16 1999-09-23 Unilever Plc Cosmetic method of treating skin
FR2777186B1 (fr) 1998-04-10 2001-03-09 Oreal Utilisation d'au moins un hydroxystilbene dans une composition raffermissante
DE19915102A1 (de) * 1999-04-01 2000-10-05 Pohl Boskamp Gmbh Chem Pharma Verwendung von Limonen zur Behandlung oxidativer Zellschädigungen
US20040161436A1 (en) * 2003-02-13 2004-08-19 Hull Barbara A. Skin treatment composition and method
FR2859908A1 (fr) 2003-09-24 2005-03-25 Oreal Composition comprenant au moins un inhibiteur de metalloproteinase et au moins un agent myorelaxant ou relaxant
KR100812596B1 (ko) * 2006-12-15 2008-03-13 바이오스펙트럼 주식회사 천연 유래 화합물을 포함하는 피부보호 조성물
CZ300806B6 (cs) * 2007-07-18 2009-08-12 Ústav experimentální mediciny AV CR, v.v.i. Imunostimulacní úcinky trilobolidu a zpusob jeho prípravy
FR2930154B1 (fr) 2008-04-21 2012-04-20 Oreal Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour maintenir et/ou restaurer la tonicite et/ou la fermete de la peau
FR2956582B1 (fr) * 2010-02-19 2012-08-24 Oreal Composition sous forme de poudre comprenant au moins une charge, au moins une huile essentielle et au moins un ester hydroxyle de polyol et d'acide(s) carboxylique(s) en c4 a c16
FR2959666B1 (fr) * 2010-05-07 2012-07-20 Oreal Composition cosmetique moussante a base d'acide ellagique ou d'un de ses derives et d'huile essentielle.
FR2962328B1 (fr) * 2010-07-12 2013-03-08 Oreal Procede de traitement des odeurs corporelles humaines utilisant une composition non rincee a base d'un compose 2-alcoxy-4-alkylcetone phenol et une huile essentielle
FR2968987B1 (fr) * 2010-12-17 2013-04-26 Oreal Huile essentielle de buplevre

Also Published As

Publication number Publication date
US20150231057A1 (en) 2015-08-20
EP2885055B1 (en) 2018-12-19
JP2015530376A (ja) 2015-10-15
EP2885055A2 (en) 2015-06-24
US10328018B2 (en) 2019-06-25
CN105050662B (zh) 2018-04-13
ES2714948T3 (es) 2019-05-30
WO2014030117A3 (en) 2014-10-23
WO2014030117A4 (en) 2014-12-11
US20190328650A1 (en) 2019-10-31
JP6382197B2 (ja) 2018-08-29
WO2014030117A2 (en) 2014-02-27
CN105050662A (zh) 2015-11-11

Similar Documents

Publication Publication Date Title
PH12020500352A1 (en) Therapeutic uses of empagliflozin
CL2019001878A1 (es) Compuestos de microarn y métodos de modulación de la actividad de mir-21 (divisional solicitud 201402844).
IN2015DN02938A (enrdf_load_stackoverflow)
EA201291031A1 (ru) Способ лечения ожирения с применением антиоксидантных модуляторов воспаления
EA201591367A1 (ru) Соединения резорцина для дерматологического применения
MX2015001250A (es) Composiciones y tratamiento para enfermedades y trastornos del ojo.
WO2014188276A3 (en) Antioxidant compositions and methods of using the same
EA201500996A1 (ru) Терапевтические применения эмпаглифлозина
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
BRPI1000320B8 (pt) Composições e métodos para tratar sinais de envelhecimento da pele
PH12017500615A1 (en) Ophthalmic composition comprising cyclosporine and trehalose
MX365366B (es) Formulaciones tópicas y orales que comprenden taurina y magnesio para la prevención y el tratamiento del acné.
MX2015003701A (es) Composiciones para tratamiento.
MX2014011855A (es) Sistemas y metodos para tratar una respuesta farmacodinamica adversa inducida por opioides.
PH12017500706B1 (en) Composition containing extract or fraction of genus justicia plant
TN2015000255A1 (fr) Chitine ou ses derives pour la prevention et/ou le traitement de parasitoses
MX359181B (es) Hidrolizado de colágeno y uso del mismo.
IN2014KN02914A (enrdf_load_stackoverflow)
IN2015KN00370A (enrdf_load_stackoverflow)
MY185412A (en) Compositions of omega 3 fatty acids to treat diseases which involve damage to the nervous system
PH12013502563A1 (en) Dha and epa in the reduction of oxidative stress
MX2014016090A (es) Composiciones moduladoras de la expresion dickkopf-1 y usos de las mismas.
BR112015020182A2 (pt) uso cosmético de queuina ou de um precursor ou um derivado dessa como ingrediente ativo, uso de queuina ou um precursor ou um derivado dessa como ingrediente ativo, composição cosmética e processo de tratamento cosmético para prevenir e/ou tratar sinais de envelhecimento da pele e/ou anexos cutâneos
WO2015050686A3 (en) Methods and compositions to inhibit metastasis and to treat fibrosis and to enhance wound healing
WO2015044317A3 (en) Staphylococcus haemolyticus inhibitors for preventing and/or treating atopic dermatitis